Global Medical Device Nomenclature (GMDN) Dr Barry Daniels Technical Lead GMDN Agency
|
|
|
- Trevor Pearson
- 6 years ago
- Views:
Transcription
1 Global Medical Device Nomenclature (GMDN) Dr Barry Daniels Technical Lead GMDN Agency
2 GMDN introduction GMDN website GMDN uses in UDI
3
4 Get from this:
5 To this?
6 Naming and grouping The role of GMDN GMDN Code: GMDN Term Name: Electrocardiographic monitor GMDN Term Definition: A mains electricity (ACpowered) bedside device designed to continuously detect, measure, and display a patient's electrocardiogram (ECG) through leads and sensors attached to the patient; it also typically displays heart rate. The device is typically equipped with audible and/or visual alarms that are triggered when the patient's parameters drop below or exceed pre-set limits.
7 GMDN grouping (GMDN Term) The GMDN term defines a lowest level generic device group Many Products assigned to 1 GMDN term Products assigned to Electrocardiographic monitor
8 Golden rule Every device (placed on the market separately) should be assigned to a single GMDN term that represents that device. A thought: If you have the device in front of you and someone asked What is that? would the GMDN term be a reasonable answer? Hopefully yes.
9 GMDN grouping (CT s) Each GMDN term is linked to many higher level (broader) Collective terms (CT s) CT s arranged in a hierarchy Therefore each Collective term creates a broader group of devices CT1444 Patient monitors/monitoring systems CT314 Electrically powered/operated
10 What does GMDN give the user The GMDN data gives the user (Regulator, Registry, Hospital, Manufacturer): A name and definition that describes the device clearly and succinctly without proprietary jargon (in up to 20 languages) A way to group the device at many levels (e.g., for inventory management, regulatory risk trending, recall analysis) A global solution: Only one code needed worldwide Allows for global analysis of data Consistent communication of data across borders
11 Collective Terms GMDN uses Collective Terms (CT s) to group/organize related Preferred terms: By clinical application (e.g., cardiovascular devices) By name (e.g., prosthesis, scissors, catheter) By attribute (e.g., Material, Invasiveness, sterility, Use frequency) A hierarchical categorisation
12 Hierarchical classification Collective Terms Nomenclature GMDN terms Collective Term Collective Term Collective Term Collective Term Collective Term Collective Term Collective Term Collective Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term GMDN Term
13 CT relationships GMDN Term GMDN Term Collective Term Collective Term Collective Term GMDN Term GMDN Term GMDN Term Collective Term GMDN Term Collective Term
14 GMDN Website Membership Search Explorer My Shortlist My Terms Enquiry
15 The Process for Manufacturer members Logon to GMDN account Search for an active GMDN term that accurately describes the device Can you find a term? Yes Click add to shortlist and purchase from shortlist No Make an Enquiry using the Enquiry wizard Communicate with GMDN team until enquiry finalized
16 GMDN Website Membership
17 GMDN Website User Management
18 The Process for Manufacturer members Logon to GMDN account Search for an active GMDN term that accurately describes the device Can you find a term? Yes Click add to shortlist and purchase from shortlist No Make an Enquiry using the Enquiry wizard Communicate with GMDN team until enquiry finalized
19 GMDN Website Search 1
20 GMDN Website Search 2
21 GMDN Website Explorer
22 Common mistake 1 A GMDN term for a system term applied to a component of the system Example: Complete system Cardiac radiofrequency ablation system System electrical cable Medical device electrical cable, reusable
23 Common mistake 2 Multiple terms assigned to a device ( often with kits, systems or implant sets) Example (in GUDID):
24 Common mistake 2 Multiple terms assigned to a device ( often with kits, systems or implant sets) Drug-eluting coronary artery stent, non-bioabsorbablepolymer-coated A sterile non-bioabsorbable metal tubular mesh structure covered with a non-bioabsorbable polymer and a drug coating that is designed to be implanted, via a delivery catheter, into a coronary artery (or saphenous vein graft) to maintain its patency typically in a patient with symptomatic atherosclerotic heart disease. The drug coating is slowly released and intended to inhibit restenosis by reducing vessel smooth muscle cell proliferation. Disposable devices associated with implantation may be included.
25 Common mistake 3 Judging the term by the name without review of the definition Ophthalmic use Is this term more appropriate? Ophthalmic surgical procedure kit, nonmedicated, single-use General surgical procedure kit, non-medicated, single-use A general-purpose collection of various sterile surgical instruments, dressings, and materials intended to be used to assist a range of surgical procedures across multiple clinical specialities. It does not contain pharmaceuticals. This is a single-use device.
26 GMDN Website Shortlist
27 GMDN Website My Terms
28 The Process for Manufacturer members Logon to GMDN account Search for an active GMDN term that accurately describes the device Can you find a term? Yes Click add to shortlist and purchase from shortlist No Make an Enquiry using the Enquiry wizard Communicate with GMDN team until enquiry finalized
29 GMDN Website - Enquiry Search first if cant find suitable term use Enquiry. Enquiry is the only way to get help from the GMDN Agency for assigning Terms to products. The outcome will be: An appropriate existing Term. Modification of an existing Term to include the new product s characteristics. A new GMDN Term is created.
30 Enquiry - list
31 Enquiry - step 1
32 Enquiry - choice
33 Enquiry - software
34 Enquiry - IVD
35 Enquiry similar term
36 Enquiry - details
37 Enquiry - end
38 Enquiry purchase new term
39 Changes to GMDN data Develop new terms (average 2-3 day) We only modify existing Terms (average 3-4 day) To increase the scope / improve the definitions We obsolete Terms (average 10/m or 0.5% per year) To remove ambiguity / term overlap GMDN is dynamic and current to keep up with innovation Members are notified about changes
40 Notifications to manufacturers You will receive alerts relating to any changes All changes will be seen at the alerts page on your account Notification s will be sent out - ensure these are received by the appropriate person You also will receive a monthly newsletter by detailing these changes
41 Regulator updates Dataset for regulators: Monthly updates: Full dataset Delta FTP API in development
42 Term details - amendments
43 Term details - amendments
44 My term has been made obsolete Again from your Alerts page open Term Details Use the Explorer Groups (aka Collective Terms) to help you find the term you need
45 How should you manage GMDN Term changes? Who needs to receive notifications? (update your account) How is this communicated internally? GMDN is a data element in the DI record that can be edited after the Grace Period. Labelers are required (per UDI Rule) to keep their device information current and correct with any data that may have changed.
46 GUDID US FDA UDI Database = GUDID Mandatory field on record submission
47
48
49 FDA GUDID August 2017 DI records: Unique GMDN codes: 8187 Therefore ratio = 1:232 Active implantable device records: 2813 Non-active implantable device records: 524,094 IVD device records: 24,817
50 GMDN Agency working with the FDA Leverage of UDI data for downstream users e.g. registries, hospitals Started with RAPID project (Pilot study MDEpiNet) Trial project for peripheral vascular intervention (PVI) registry Focus on peripheral stents FDA have now created a Learning UDI Community initiative with a focus on GMDN led device categorisation Helping to improve GMDN definitions and user assignment of terms.
51 Device Identification - UDI GMDN CTs GMDN Terms Devices 51 of 35
52 A device has a new component Shared Data Information For Users (IFU) Document data Publically shared data (inc. GMDN term assignment) sent to Regulators and Customers (e.g., via GDSN) 52 of 35
53 GMDN in Hospitals Asset Management Support equipment commissioning Help identify equipment location Support maintenance programmes Inventory Control Reduce wastage Translate product labels with poor descriptions Improve stock control Replace existing inventory classification with an externally managed globally recognized nomenclature
54 Equipment Commissioning Nottingham University Hospitals NHS Trust
55 What s UDI? A UDI ISSUING AGENCY provides THE MANUFACTURER with A UNIQUE NUMBER to be put in A BARCODE for THE DEVICE allowing accurate RETRIEVAL of DEVICE DATA from A DATABASE
56 What does the GMDN do? A DEVICE is assigned to A GMDN Term which creates A GENERIC DEVICE GROUP within A DATABASE and allows for HARMONIZED NAMING
57 What s the GMDN Process? THE GMDN Term is assigned to THE DEVICE by THE MANUFACTURER for REGULATORS and HOSPITALS
58 GMDN is improving communication GMDN is now the global language
59 Thank you for listening Any questions now? Website: gmdnagency.org Enquiry product/term Contact us anything else
A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION. Vascular Implant Surveillance & Interventional Outcomes Network
A Coordinated Registry Network Based on the Vascular Quality Initiative: VISION Vascular Implant Surveillance & Interventional Outcomes Network Jack L. Cronenwett, MD Medical Director, Society for Vascular
Unique Device Identifier (UDI) Labeling
INFORMATION SHEET Unique Device Identifier (UDI) Labeling On September 24, 2013, the United States Food and Drug Administration (FDA) released a final rule requiring that most medical devices distributed
1WorldSync. 1WorldSync FDA UDI Compliance. April 11, 2017
1WorldSync 1WorldSync FDA UDI Compliance Experience Presentation in Japan and TitleKorea April 11, 2017 Agenda About 1WorldSync FDA UDI Compliance Experience in Japan and Korea What s Coming Next FDA GUDID
2013 May expect UDI Final Rule. This put a date on when the draft of the proposed rule had to be released
2011 Global Harmonization Task Force (GHTF) UDI Guidance published 2012 FDA Proposed Regulation Publishes 2012 FDA Safety and Innovation Act (FDASIA) provisions added This put a date on when the draft
Moving UDI from Regulation to Value Within Hospitals and Beyond
Moving UDI from Regulation to Value Within Hospitals and Beyond Karen Conway Executive Director, Industry Relations, GHX Terrie Reed, MDEpiNet Coordinating Center Duke Clinical Research Institute Slide
GS1 Guide on Unique Device Identification (UDI) implementation
GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.
The GS1 System and services (GTIN, GLN and GDSN) can be used to comply with this rule.
Department of Health and Human Services Food and Drug Administration Unique Device Identification System Proposed Rule Executive summary On Tuesday, July 10, 2012 the Food and Drug Administration issued
University Health Network UDI Capture Work Group Case Study
LEARNING UDI COMMUNITY University Health Network UDI Capture Work Group Case Study WWW.AHRMM.ORG / LUC WORK GROUP TITLE: UDI Capture Work Group CASE STUDY PARTICIPANTS Wendy Watson, OR Supply Chain Manager
RE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System
November 7, 2012 Margaret Hamburg Commissioner Food and Drug Administration Department of Health and Human Services Room 2217 White Oak Building One 10903 New Hampshire Avenue Silver Spring, MD 20993 RE:
WHITE PAPER. Everything You Need To Know About the FDA UDI Rule
Everything You Need To Know About the FDA UDI Rule Basics In creating the UDI system, the FDA aimed to reduce the burden on the healthcare industry by building on systems that are already in place. The
UDI Guidance Document for Medical Devices Containing HCT/P
LEARNING UDI COMMUNITY UDI Guidance Document for Medical Devices Containing HCT/P WWW.AHRMM.ORG / LUC INTRODUCTION: Human cells, tissues, or cellular or tissue-based products (HCT/Ps) are a precious resource
UDI in the US. Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration. 19 October 2017
UDI in the US Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration 19 October 2017 UDI: Regulatory Update Terrie L. Reed, MS. Ind. Engineering Center for Devices and Radiological
MJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync
MJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync GDSN implementation, UDI Databases and product data for hospitals MJ Wylie, Global GDSN Deployment, Johnson & Johnson Nick Manzo, Global Senior Director
Management of Clinically Significant Device Attributes not Contained in the GUDID: Augmented Unique Device Identifier Data AUDI
Management of Clinically Significant Device Attributes not Contained in the GUDID: Augmented Unique Device Identifier Data AUDI Report of the MDEpiNet AUDI Workgroup MISSION: Provide the framework for
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
There are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction
There are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction John F. Kennedy 12 May 1961 Annual Convention American for Democratic
UDI: From Compliance to Value OMTEC June 2013 Karen Conway
UDI: From Compliance to Value OMTEC June 2013 Karen Conway 1 GHX GHX proprietary information: Please do not not copy copy or or distribute UDI: The Reality UDI: The Reality UDI: The Reality UDI: The Reality
UDI (Unique Device Identification) and patient safety latest regulatory developments
UDI (Unique Device Identification) and patient safety latest regulatory developments Ulrike Kreysa, VP Healthcare, GS1 Global Office Medical Devices Innovation Program Munich, 14 October 2016 Agenda UDI
Terumo Cardiovascular Systems and UDI; An Unexpected Voyage
Terumo Cardiovascular Systems and UDI; An Unexpected Voyage GHX 2013 proprietary Global Healthcare information. Exchange, Do not copy LLC. or All distribute. rights reserved. Agenda Overview of Terumo
UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014
UNIQUE DEVICE IDENTIFICATION U.S. FDA March 2014 Introduction The Food and Drug Administration (FDA) has released a final rule requiring most medical devices distributed in the United States to carry a
Bioabsorbable metal stents: properties, modeling and open questions
Biomedical Engineering Bioabsorbable metal stents: properties, modeling and open questions Palma Tartaglione Supervisor: Prof. Ferdinando Auricchio Co-supervisor : Ing. Mauro Ferraro December 16, 2014
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
The role of SNOMED CT in healthcare systems across the world Jan-Eric Slot MB MSc MBA CEO IHTSDO
The role of SNOMED CT in healthcare systems across the world Jan-Eric Slot MB MSc MBA CEO IHTSDO International Health Terminology Standards Development Organisation www.ihtsdo.org 1 Outline What is the
Andrea Mitchell. Medtronic
Andrea Mitchell Medtronic April 20, 2016 UNIQUE DEVICE IDENTIFICATION: Experiences with implementation of the U.S. FDA UDI Rule ANDREA MITCHELL MITG RA OPERATIONS MANAGER OUR MISSION, TENET #3: To strive
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
Florence Nightingale Notes on hospitals (1859, revised 1863)
In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records fit for any purposes of comparison. If they could
Laboratorio di Tecnologie Biomediche
Laboratorio di Tecnologie Biomediche Introduction to medical devices Carmelo De Maria carmelo.demaria@unipi.it Medical Device A Medical Device is identified by means of its INTENDED PURPOSE Intended to
IMDRF. Final Document. UDI Guidance Unique Device Identification (UDI) of Medical Devices. IMDRF UDI Working Group
IMDRF International Medical Device Regulators Forum Final Document Title: UDI Guidance Unique Device Identification (UDI) of Medical Devices Authoring Group: IMDRF UDI Working Group Date: 9 December 2013
First Global Forum on Medical Devices Bangkok-Thailand, September Regulatory Control of Medical Devices in Tanzania
First Global Forum on Medical Devices Bangkok-Thailand, September 9-11 2010 Regulatory Control of Medical Devices in Tanzania Mr. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority hiiti@yahoo.com/hiiti.sillo@tfda.or.tz
Leveraging Big Data to Mitigate Medical Device Risks. August 8, 2017
Leveraging Big Data to Mitigate Medical Device Risks August 8, 2017 Presenters Nicolas Tasse-Guillen Sr. Product Manager, Life Sciences Rachel Benway Assoc. Product Manager, Life Sciences A spotlight has
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
NEW EU Regulations and the EU UDI system
NEW EU Regulations and the EU UDI system 24 October 2017, Brussels Géraldine Lissalde-Bonnet Director Public Policy, GS1 Global Office Disclaimer Neither GS1 nor its member organizations nor their staffs
UDI: The Ins and Outs of Global Compliance and Value
UDI: The Ins and Outs of Global Compliance and Value Karen Conway Executive Director GHX Jay Crowley Vice President USDM OMTEC 2015 Copyright 2015 by USDM Life Sciences Introductions Jay Crowley VP of
November 1, Unique Device Identification System. Dear Dr. Hamburg:
November 1, 2012 Margaret A. Hamburg, M.D. Commissioner Food and Drug Administration Department of Health and Human Services Attention: FDA-2011-N-0090 Submitted electronically at: http://www.regulations.gov
Utilization of UDI during the Product Recall. 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey
Utilization of UDI during the Product Recall 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey 1 Speaker Biography Director, Corporate Post Market Surveillance, Terumo Cardiovascular Group 16
China-EU Competition Week: Abbott's Acquisition of St. Jude Medical
China-EU Competition Week: Abbott's Acquisition of St. Jude Medical Anti-monopoly Bureau, MOFCOM Tang Yu March 2017 Part I: basic information of the case Part II: definition of relevant markets and competitive
WHITE PAPER. A Consulting Approach to Unique Device Identifier (UDI) Adoption. Abstract
WHITE PAPER A Consulting Approach to Unique Device Identifier (UDI) Adoption - Kunal Verma, Life Sciences and Services, Infosys Consulting - Dinesh Peter, Life Sciences and Services, Infosys Consulting
Clinical Integration Track: It s All About the Data
Clinical Integration Track: It s All About the Data Presenters: Sandi Michel, Director of Systems & Quality The Office of Data Standards & Interoperability Franciscan Missionaries of Our Lady Health System
UDI 101: What You Need to Know About Unique Device Identifiers
UDI 101: What You Need to Know About Unique Device Identifiers Lena Cordie Qualitas Professional Services 2015 Qualitas Professional Services. All rights reserved. Presentation Objectives: Understanding
ISO Cardiovascular implants Endovascular devices Part 2: Vascular stents Part 2: Vascular stent
INTERNATIONAL STANDARD ISO 25539-2 Second edition 2012-12-01 Cardiovascular implants Endovascular devices Part 2: Vascular stents Part 2: Vascular stent Implants cardiovasculaires Dispositifs endovasculaires
Unique Device Identification. Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936 Visibility of Device Identification Manufacturer Medical Device
Global Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors
Quality Assurance Global Medical Device Nomenclature: The Concept for Reducing Device-Related Medical Errors Anand K, Saini SK 1, Singh BK 2, Veermaram C Department of Pharmaceutics, Faculty of Pharmaceutical
October 26, Unique Device Identification System (FDA-2011-N-0090) Dear Commissioner Hamburg:
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org October 26, 2012 Margaret A. Hamburg, MD Commissioner Division of Dockets Management
The UDI Experience: From a US Perspective
Simposio Nazionale Bergamo, Italy Saturday 6 May 2017 The UDI Experience: From a US Perspective Lena Cordie Qualitas Professional Services 2017 Qualitas Professional Services, LLC. All rights reserved.
May Yip Chief Supplies Officer Hospital Authority. Collaborative ecommerce and Safe Supply Chain Management
May Yip Chief Supplies Officer Hospital Authority Collaborative ecommerce and Safe Supply Chain Management Agenda Overview of Hospital Authority ecommerce Development in Hospital Authority Safe Supply
Keeping Patients and Medical Professionals at the Center of Everything We Do
Keeping Patients and Medical Professionals at the Center of Everything We Do To fulfill its corporate mission of Contributing to Society through Healthcare, Terumo continually rises to the challenge of
Unique Device Identification: Unambiguous, Standardized and Harmonized
Unique Device Identification: Unambiguous, Standardized and Harmonized Jay Crowley Senior Advisor for Patient Safety Federal Device Administration jay.crowley@fda.hhs.gov 301-980-1936 2011- Year of the
Unique Device Identification (UDI)
Unique Device Identification (UDI) How GS1 standards can help you comply with UDI regulations Supported by Medical device suppliers and manufacturers do you comply with UDI? If you supply medical devices
Advancing minimally invasive. therapeutics through novel device. development. Minima y Invasive New Technologies T H E L E O N A M. A N D H A R R Y B.
MIN T Minima y Invasive New Technologies Advancing minimally invasive therapeutics through novel device development T H E L E O N A M. A N D H A R R Y B. C H A R I T A B L E T R U S T he Minimally Invasive
ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA
Post Marketing Safety Reporting (PMSR) Challenges and Successful Practices for Combination Products Objective Session Goals Summary of the final rule Interpretation for combination products approved as
Perfect Order and Beyond
Perfect Order and Beyond GS1 Healthcare User Group Australasia New Zealand Chapter 2015-09-15 Dennis Black, Director, e-business Solutions Group BD BD is a leading medical technology company that partners
EUROPEAN COMMISSION. Brussels, 04.IV.2006 C(2006)1189 final. State aid N 639/2005 Ireland Abbott Vascular Devices Ireland. Sir, 1.
EUROPEAN COMMISSION Brussels, 04.IV.2006 C(2006)1189 final Subject: State aid N 639/2005 Ireland Abbott Vascular Devices Ireland Sir, 1. PROCEDURE (1) The Irish authorities notified the abovementioned
The UDI Experience: From a US Perspective
IRIC Conference Glasgow Scotland Monday 22 August 2016 The UDI Experience: From a US Perspective Lena Cordie Qualitas Professional Services 2016 Qualitas Professional Services, LLC. All rights reserved.
The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office
The world of GS1 standards in healthcare Chris Adcock GS1 Global Office Topics Background Where we are going Where we are today What this means to you Questions Background Topics Where we are going Where
HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737)
MDA/GL No 1: July 2013 Guidelines for implementation of medical device regulatory system HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737) [Appendix 4 Schedule 3 Medical
Food and Drug Administration; Unique Device Identification System. [Docket No. FDA-2011-N-0090] Summary of Proposed Rule
![Food and Drug Administration; Unique Device Identification System. [Docket No. FDA-2011-N-0090] Summary of Proposed Rule](/thumbs/77/76516039.jpg "Food and Drug Administration; Unique Device Identification System. [Docket No. FDA-2011-N-0090] Summary of Proposed Rule")
Food and Drug Administration; Unique Device Identification System Introduction [Docket No. FDA-2011-N-0090] Summary of Proposed Rule On July 10, 2012, the Food and Drug Administration (FDA) published a
Novel BioResorbable Vascular Platforms from India
DEEP DIVE SESSION: Lower limb interventions (part II) Femoropopliteal, drug-eluting devices, and new technologies Time 11:55am to 12:01pm Novel BioResorbable Vascular Platforms from India Dr. Vimal Someshwar
Laboratorio di Tecnologie Biomediche
Laboratorio di Tecnologie Biomediche Introduction to medical devices Carmelo De Maria carmelo.demaria@unipi.it Medical Device A Medical Device is identified by means of its INTENDED PURPOSE Intended to
November 6, Submitted electronically at:
Submitted electronically at: http://www.regulations.gov Margaret A. Hamburg, MD Commissioner Food and Drug Administration U.S. Department of Health and Human Services 5630 Fishers Lane, room 1061 Rockville,
MAIMONIDES MEDICAL CENTER
MAIMONIDES MEDICAL CENTER CODE: AD-088 (Revised) ORIGINALLY ISSUED: October 2, 1990 SUBJECT: Product Safety Recall and Alert I POLICY In the event of a product safety recall or alert of a medical device
QUADRA FAMILY OF MEDICAL POLYURETHANES POLYMER SOLUTIONS FOR THE HEALTHCARE MARKET
QUADRA FAMILY OF MEDICAL POLYURETHANES POLYMER SOLUTIONS FOR THE HEALTHCARE MARKET Applications Biomerics is an innovative, polymer solution provider to the medical device and biotech industries. We specialize
GHTF Draft Proposal for. Unique Device Identification (UDI) System for Medical Devices
GHTF/AH/(PD2)N2R2 GHTF Draft Proposal for a draft guidance on Unique Device Identification (UDI) System for Medical Devices Authoring Group: GHTF SC UDI AHWG Proposed by the Global Harmonization Task Force
Overcome inventory management challenges with our comprehensive suite of solutions
Inventory Management Solutions Overcome inventory management challenges with our comprehensive suite of solutions RFID-enabled Smart Cabinets RFID-enabled Smart Cabinets RFID-enabled Smart Wand RFID-enabled
Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare
Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare International Organisation for Standardization European Committee for Standardization Health Level 7 international International Health
Clinical Evaluation and Clinical Investigation update MDR
Clinical Evaluation and Clinical Investigation update MDR December 5 th, 2017 Carine Cochereau, Cardinal Health Slide 1 Directives: obligation for Member State (MS) to implement provisions into their national
LUC UOU Examples Talk Track
LUC UOU Examples Talk Track (Slide 1): Welcome to the AHRMM Learning UDI Community. This presentation is intended to provide more information on potential use cases for the Unit of Use (also known as the
McKesson Cardiology Bringing together all the cardiovascular information you need into a single platform
Care Providers Hospitals and Health Systems Enterprise Image and Information Management McKesson Cardiology Bringing together all the cardiovascular information you need into a single platform Catheterization
B.Braun: Global Regulatory Compliance Achieves Additional Benefits
TM CASE STUDY B.Braun: Global Regulatory Compliance Achieves Additional Benefits Challenge The healthcare landscape is experiencing a significant transformation. Today s patients are savvy consumers, demanding
Information Management FAQ for UDI
White Paper Information Management FAQ for UDI 20 Questions & Answers about Complying with the FDA Requirement for Unique Device Identification (UDI) This document contains Confidential, Proprietary and
Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President
Unique Device Identification Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President Ombu Enterprises, LLC Dan@OmbuEnterprises.com www.ombuenterprises.com 603-209-0600 1 Outline Medical Device Regulation
A Case Study of the Challenges of Global Labeling and it s Impact on the Supply Chain. Medical Device Supply Chain Council October 2 nd, 2013
A Case Study of the Challenges of Global Labeling and it s Impact on the Supply Chain Medical Device Supply Chain Council October 2 nd, 2013 1 Agenda Today s Discussion Items Company Overview Hidden challenges
Are you ready for UDI?
Are you ready for UDI? Improved outcomes through product identification Unique Device Identification (UDI) has been recognized as a key tool in improving patient outcomes. More efficient recall procedures,
was published. February 21, 2017
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
Post market Surveillance ISO EU Medical Device Regulation
Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes
MEDDEV 2.2/3 Rev 3 Use-By Date June 1998
European Guidance Document: MEDDEV 2.2/3 Rev 3 Use-By Date June 1998 About Emergo Group: Emergo Group provides regulatory and quality assurance consulting for medical device companies. Specialties include
MEDICAL DEVICES REGULATORY SYSTEM
GUIDANCE DOCUMENT MEDICAL DEVICES REGULATORY SYSTEM Table of Contents PART 1: PRE-MARKET ASSESSMENT 9 SECTION 1: INTRODUCTION 9 1.1 Principles and Main Features of A Regulatory Framework of Medical Device
Strategic Implications of UDI and Contract Administration
What? Strategic Implications of UDI and Contract Administration 2014 Fall Conference Dec 9 11, 2014 OMNI Hotel, Chicago Danny Adams President and CEO Distributor Data Solutions (DDS) Elizabeth Hilla Senior
Cardiac Rhythm Management // Patient Brochure // BioMonitor 2. BioMonitor 2. Patient Information
Cardiac Rhythm Management // Patient Brochure // BioMonitor 2 BioMonitor 2 Patient Information BioMonitor 2 We Listen to Your Heart Dear patient, Your doctor has decided to implant a cardiac monitor BioMonitor
The Long and Winding Road of Unique Device Identifier (UDI) Implementation: A Small Company Perspective
The Long and Winding Road of Unique Device Identifier (UDI) Implementation: A Small Company Perspective Daniel Simpson, RAC (US,CAN), ASQ CBA Sr. Director of Quality and Regulatory Affairs Corgenix, Inc
FDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond
FDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond Jeff Shuren, MD, JD Center for Devices and Radiological Health U.S. Food and Drug Administration May 4, 2017 1
Bioabsorbable Stents - Medical Devices Pipeline Assessment, 2015
Bioabsorbable Stents - Medical Devices Pipeline Assessment, 2015 Bioabsorbable Stents - Medical Devices Pipeline Assessment, 2015 BioPortfolio has been marketing business and market research reports from
AIOS ASSOCIAZIONE ITALIANA OPERATORI SANITARI ADDETTI ALLA STERILIZZAZIONE
AIOS ASSOCIAZIONE ITALIANA OPERATORI SANITARI ADDETTI ALLA STERILIZZAZIONE (Italian Association of Sterilization Operators working in health care facilities) 1 WFHSS 2007 - WORLD CONFERENCE FOR HOSPITAL
Re: Comments on Unique Device Identification System; Proposed Rule; Docket No. FDA-2011-N-0090 / RIN No AG31
1227 25th Street, NW Washington, D.C. 20037-1156 October 24, 2012 VIA ELECTRONIC SUBMISSION Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville,
Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
Due diligence in the European medical devices industry
Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's
Combination products Updates Final FDA Guidance
Compliance Seminars Combination products Updates Final FDA Guidance Presented by Anna Lundén Webinar, March 8, 2017 Intentionally blank Compliance Seminars Our international course program for GMP professionals
Optima IGS 330 Versatility within your reach. gehealthcare.com
Optima IGS 330 Versatility within your reach gehealthcare.com Versatility within your reach Whether you are creating a new diagnostic service to improve access to patient care or building an additional
Human Research Protection Program Guidance for Human Research Determination
Human Research Protection Program Guidance for Human Research Determination I.1.A The sole purpose of the Institutional Review Board (IRB), as defined in federal statutes, is the protection of human subjects
Medical Devices. The technical requirements also apply when the submitter is not the legal manufacturer 1 (i.e: a distribution company).
UNFPA Technical requirements for medical devices 1. Introduction The following document provides UNFPA s technical requirements in the procurement of medical devices (medical equipment, renewable medical
Precision Vascular Robotics. Corindus Vascular Robotics (CVRS) January 2018
Precision Vascular Robotics Corindus Vascular Robotics (CVRS) January 2018 1 Forward Looking Statements This presentation contains forward-looking statements (as such term is defined in Section 27A of
Quality Assurance with Rigid Containers Katrina Simpson, M.A., CST, CSPDT
Page 2 I HEARD IT THROUGH THE STEAMLINE Quality Assurance with Rigid Containers Katrina Simpson, M.A., CST, CSPDT Objectives: Discuss various quality assurance issues regarding rigid containers. Discuss
Government Management Committee. Chief and General Manager, Toronto EMS Director of Purchasing and Materials Management Division
STAFF REPORT ACTION REQUIRED Sole source contract for proprietary consumable supplies, operating accessories and service with Zoll Medical Canada Inc. for monitor/defibrillator equipment Date: May 16,
A Report to Our Valued Clients. January 2013
A Report to Our Valued Clients January 2013 C L I E N T R E P O R T P A G E 2 From the desk of Chris Winquist, Chief Operations Officer As always, our intention is to increase your satisfaction through
A Report to Our Valued Clients. April 2013
A Report to Our Valued Clients April 2013 From the desk of Chris Winquist, President & Chief Operations Officer As always, our intention is to increase your satisfaction with LUMEDX through improved software,
Current Trends at FDA: Implications for Data Requirements
Introduction The environment surrounding medical device regulation in the United States has always been rigorous, but recent events including well-publicized quality issues associated with implantable